Melisa Laboratorium - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 956,598 | 824,296 | 833,553 | 748,889 | 484,344 | 780,040 | 623,611 | 727,893 |
| Profit before tax | -42,743 | -8,162 | 51,592 | 23,181 | -64,409 | 76,720 | 1,522 | 33,023 |
| Net profit | -42,743 | -8,162 | 51,592 | 25,865 | -64,409 | 73,260 | 1,286 | 27,731 |
| Equity | -93,985 | -102,147 | -50,555 | -30,058 | -94,467 | -21,207 | -19,921 | 7,810 |
| Liabilities | 626,172 | 567,924 | 536,130 | 575,125 | 539,886 | 380,014 | 467,026 | 0 |
| Non-current assets | 72,793 | 63,932 | 55,227 | 48,254 | 40,522 | 34,021 | 27,429 | 21,721 |
| Current assets | 469,025 | 423,953 | 453,712 | 513,399 | 418,579 | 335,511 | 427,652 | 334,704 |
| Total assets | 541,818 | 487,885 | 508,939 | 561,653 | 459,101 | 369,532 | 455,081 | 356,425 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 34,752 | 11,960 | - |
| Social insurance contributions | - | - | - | - | - | 47,416 | 43,318 | 39,193 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -0.8% | -13.8% | +1.1% | -10.2% | -35.3% | +61.1% | -20.1% | +16.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -7.9% | -1.7% | 10.1% | 4.6% | -14.0% | 19.8% | 0.3% | 7.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | 355.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -4.5% | -1.0% | 6.2% | 3.5% | -13.3% | 9.4% | 0.2% | 3.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -4.5% | -1.0% | 6.2% | 3.1% | -13.3% | 9.8% | 0.2% | 4.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 34,369 | 31,302 | 36,241 | 35,381 | 25,161 | 44,574 | 44,019 | 57,846 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Melisa Laboratorium - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-23 | 2026-07-26 | 0.88 |
| 2025-10-23 | 2025-11-06 | 3.77 |
| 2025-07-24 | 2025-08-17 | 1.65 |
| 2025-07-16 | 2025-07-20 | 2328.65 |
| 2025-05-04 | 2025-05-07 | 7.78 |
| 2025-05-01 | 2025-05-01 | 7.78 |
| 2025-04-24 | 2025-04-29 | 7.78 |
| 2025-04-17 | 2025-04-17 | 34.16 |
| 2025-04-16 | 2025-04-16 | 3040.05 |
| 2025-03-03 | 2025-03-03 | 2875.41 |
| 2025-02-18 | 2025-02-26 | 2875.41 |
| 2025-01-22 | 2025-02-17 | 1.01 |
| 2024-10-24 | 2024-11-14 | 6.37 |
| 2024-09-17 | 2024-09-17 | 3489.30 |
| 2024-07-16 | 2024-07-18 | 3747.13 |
| 2024-06-18 | 2024-06-24 | 4035.60 |
| 2024-04-23 | 2024-05-15 | 8.08 |
| 2024-01-23 | 2024-02-14 | 3.01 |
| 2024-01-16 | 2024-01-22 | 3365.85 |
| 2023-10-25 | 2023-11-06 | 1.18 |
| 2023-10-17 | 2023-10-18 | 3466.33 |
| 2023-07-28 | 2023-08-16 | 1.06 |
| 2023-07-24 | 2023-07-25 | 1.06 |
| 2023-01-24 | 2023-01-31 | 2.24 |
| 2022-10-18 | 2022-10-18 | 3733.75 |
| 2022-09-16 | 2022-09-18 | 3466.85 |
| 2022-04-28 | 2022-05-11 | 0.97 |
| 2022-01-31 | 2022-02-13 | 0.50 |
Melisa Laboratorium - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-11 | 2024-12-11 | 11.64 |
| 2024-12-10 | 2024-12-10 | 11.64 |
| 2024-12-08 | 2024-12-09 | 11.64 |
| 2024-12-06 | 2024-12-07 | 11.64 |
| 2024-12-05 | 2024-12-05 | 11.64 |
| 2024-12-04 | 2024-12-04 | 11.64 |
| 2024-12-03 | 2024-12-03 | 11.64 |
| 2024-12-01 | 2024-12-02 | 11.64 |
| 2024-11-29 | 2024-11-30 | 11.64 |
| 2024-11-28 | 2024-11-28 | 11.64 |
| 2024-11-27 | 2024-11-27 | 0.0 |
| 2024-11-26 | 2024-11-26 | 0.0 |
| 2024-11-25 | 2024-11-25 | 0.0 |
| 2024-11-24 | 2024-11-24 | 0.0 |
| 2024-11-22 | 2024-11-23 | 0.0 |
| 2024-11-20 | 2024-11-21 | 0.0 |
| 2024-11-18 | 2024-11-19 | 0.0 |
| 2024-11-17 | 2024-11-17 | 0.0 |
| 2024-10-16 | 2024-11-16 | 0.0 |
| 2024-10-14 | 2024-10-15 | 2.71 |
| 2024-10-10 | 2024-10-13 | 2.71 |
| 2024-10-09 | 2024-10-09 | 2.71 |
| 2024-10-07 | 2024-10-08 | 2.71 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Melisa Laboratorium, UAB (company code 123631164) is a Private Limited Liability Company engaged in the manufacture of soap and detergents, cleaning and polishing preparations. In 2025, revenue reached €727.9K, increasing 16.7% year on year, while net profit amounted to €27.7K and the profit margin was 3.8%. The 2025 result marked a clear recovery from 2024, when revenue was €623.6K and net profit only €1.3K, after a stronger 2023 with €780.0K revenue and €73.3K net profit. Over the two-year period, revenue remained 6.7% below 2023, but profitability improved sharply from the 2024 low. At the end of 2025, total assets stood at €356.4K, with long-term assets of €21.7K and short-term assets of €334.7K. Equity turned positive at €7.8K, after negative equity of €19.9K in 2024 and -€21.2K in 2023. The equity ratio was 2.2%, asset turnover was 2.04x, return on assets was 7.8%, and revenue per employee was €60.7K.